Article Details

Has pharma missed the boat?

Retrieved on: 2021-04-28 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

Has pharma missed the boat?. View article details on hiswai:

Excerpt

A second issue afflicting the industry's ESG rating is affordability and pricing, with 12 firms scoring negatively on this issue. While AstraZeneca offered to ...

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up